Cite
HARVARD Citation
Kristin Schmitz, A. et al. (2021). Diagnostic impact of additional O-(2-[18F]fluoroethyl)-L-tyrosine (18F-FET) PET following immunotherapy with dendritic cell vaccination in glioblastoma patients. British journal of neurosurgery. pp. 736-742. [Online].